AUG 03, 2021 7:00 AM PDT

Some Neutralizing Antibodies Make COVID Worse

WRITTEN BY: Tara Fernandez

Antibodies are specialized proteins produced as part of the body's immune response. Neutralizing antibodies bind to pathogens, such as SARS-CoV-2, stopping it from infecting host cells. Neutralizing antibodies have shown immense promise as COVID-19 treatments. These Y-shaped proteins block the coronavirus from slipping into human cells, obstructing interactions between the virus' spike protein and ACE2 cell-surface receptors.

Several clinical trials have shown that these antibodies when administered early after a diagnosis, may prevent hospitalization in patients at high risk for severe complications from the disease. 

The immune system produces such a vast universe of neutralizing antibodies against a single viral target, each with distinct properties. Some might bind more strongly to the spike protein, for instance. However, until now, questions have lingered on how to rank the potency of discovered SARS-CoV-2 antibodies based on their characteristics. Would neutralizing antibodies that latch on more strongly to the spike protein have more therapeutic value for COVID-19 patients?

No, says a study published in the high-impact journal Cell, providing evidence that neutralizing antibodies are far more complex than initially thought. In the investigation, scientists analyzed a panel of six antibodies known to target the SARS-CoV-2 spike protein specifically. As predicted, these antibodies all had a specific affinity for the spike protein. 

Unexpectedly, however, a subset of these neutralizing antibodies bound to sites on the spike protein actually enhanced binding to ACE2. Here, antibody binding locked the spike protein in a molecular conformation typically seen in its "pre-binding" state.

Interestingly, while theoretically classed as neutralizers, these antibodies triggered the formation of cell fusions called syncytia—a phenomenon associated with extensive lung damage in patients with severe COVID-19 symptoms. "We show that stabilization of different Spike conformations leads to modulation of Spike-mediated membrane fusion with profound implications for COVID-19 pathology and immunity," wrote the authors.

Together, these and other findings as part of the study provide new guidelines for drug developers with therapeutic neutralizing antibodies in their pipelines, highlighting the importance of studying antibody binding on a structural level to predict their dynamics in vivo.

 

Source: Cell


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 17, 2021
Immunology
How T Cells Sense Dangerous Invaders
JUN 17, 2021
How T Cells Sense Dangerous Invaders
T cells form a major part of our immune defenses, protecting us against the constant barrage of potentially pathogenic p ...
JUN 28, 2021
Cell & Molecular Biology
Bringing Light to Extracellular Vesicles
JUN 28, 2021
Bringing Light to Extracellular Vesicles
Though originally thought of as strictly a waste disposal system, extracellular vesicles (EVs) have been shown to have m ...
AUG 10, 2021
Immunology
An Immune Molecule Helps Create 'Good' Fat
AUG 10, 2021
An Immune Molecule Helps Create 'Good' Fat
Not all fat is ‘bad’—there’s white fat that builds up when excess calories are consumed. But, th ...
AUG 31, 2021
Health & Medicine
People Who Have Had SARS-CoV-2 Infection Have Longer-Lasting Immunity Than Those Who Were Vaccinated Only
AUG 31, 2021
People Who Have Had SARS-CoV-2 Infection Have Longer-Lasting Immunity Than Those Who Were Vaccinated Only
Consider yourself among the luckiest if you made a full recovery from infection with SARS-CoV-2, especially if you were ...
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
SEP 16, 2021
Immunology
Trapped! An Immune Cell Tag Team Takes Down Bacteria.
SEP 16, 2021
Trapped! An Immune Cell Tag Team Takes Down Bacteria.
Spiders are among nature’s most sophisticated hunters. Many build intricate webs out of silk and lie in wait for a ...
Loading Comments...